AzTrials
AzTrials

Knee ArthropathyNCT05170321

Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China

An observational study of Knee Arthropathy and Hip Arthropathy, run by Xiangya Hospital of Central South University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The project intends to analyze the epidemiological characteristics, risk factors, complications and resource utilization of artificial joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). Read more about this study

Who is it for?
Any age
How many people
600,000 participants
Where
1 siteChina
Study dates
1 Jan 2018to 1 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients who underwent knee, hip, shoulder, ankle and elbow arthroplasty were included.

Who may be able to join

  • Patients who underwent knee, hip, shoulder, ankle and elbow arthroplasty in HQMS

Who cannot join

  • Patients who didn't undergo knee, hip, shoulder, ankle and elbow arthroplasty
  • Patients with missing demographics or medical data

Trial locations and contacts

1 site in 1 country.

China1 site
  • Xiangya Hospital of Central South University

    Changsha, Hunan, 410008

Other trials in China

About this study

The project intends to analyze the epidemiological characteristics, risk factors, complications and resource utilization of artificial joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The HQMS database is a mandatory electronic inpatient database system developed by the National Health Commission of the People's Republic of China. Since 2013, tertiary hospitals have been required to upload their inpatient discharge records. By 2019, the HQMS database has included more than 230 million standardized inpatient discharge records of over 1000 hospitals across all 31 provincial-level administrative regions in mainland China. Patient demographics, clinical diagnosis, procedures and operations, drug use, costs and complications were all recorded in the HQMS database. The investigators planned to include five types of arthroplasty, including knee arthroplasty, hip arthroplasty, shoulder arthroplasty, ankle arthroplasty and elbow arthroplasty. The data analysis will be conformed to the principle of confidentiality and will not reveal the privacy of those patients. The data will be only used for this research project and there is no conflict of interest. It is in line with the principles of ethics, harmlessness and fairness. This study was authorized by the HQMS Committee Board and approved by the institutional review board, with waiver of informed consent.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05170321
Study groupRoleWhat they receive
patients undergoing knee arthroplasty in Hospital Quality Monitoring System in ChinaPatients who underwent knee arthroplasty and was recorded in HQMS were included in this group
patients undergoing hip arthroplasty in Hospital Quality Monitoring System in ChinaPatients who underwent hip arthroplasty and was recorded in HQMS were included in this group
patients undergoing shoulder arthroplasty in Hospital Quality Monitoring System in ChinaPatients who underwent shoulder arthroplasty and was recorded in HQMS were included in this group
patients undergoing ankle arthroplasty in Hospital Quality Monitoring System in ChinaPatients who underwent ankle arthroplasty and was recorded in HQMS were included in this group
patients undergoing elbow arthroplasty in Hospital Quality Monitoring System in ChinaPatients who underwent elbow arthroplasty and was recorded in HQMS were included in this group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Epidemiological characteristics, complications, risk factors and resource utilization of knee arthroplasty in China

    The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial knee joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.

    Measured: 10 years (2013-2022)

  2. Epidemiological characteristics, complications, risk factors and resource utilization of hip arthroplasty in China

    The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial hip joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.

    Measured: 10 years (2013-2022)

  3. Epidemiological characteristics, complications, risk factors and resource utilization of shoulder arthroplasty in China

    The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial shoulder joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.

    Measured: 10 years (2013-2022)

  4. Epidemiological characteristics, complications, risk factors and resource utilization of ankle arthroplasty in China

    The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial ankle joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.

    Measured: 10 years (2013-2022)

  5. Epidemiological characteristics, complications, risk factors and resource utilization of elbow arthroplasty in China

    The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial elbow joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.

    Measured: 10 years (2013-2022)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2021
  2. Study start1 Jan 2018
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion1 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
600,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05170321
Sponsor's protocol ID
2017121016
Status last verified
Nov 2021
First submitted
8 Dec 2021
Last updated
14 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The investigators do not wish to share our data according to the policy of our hospital, the data could not be shared with others without permission.

Publications

  • Zeng C, Lane NE, Englund M, Xie D, Chen H, Zhang Y, Wang H, Lei G. In-hospital mortality after hip arthroplasty in China: analysis of a large national database. Bone Joint J. 2019 Oct;101-B(10):1209-1217. doi: 10.1302/0301-620X.101B10.BJJ-2018-1608.R1.

    PubMed 31564156
  • Wang Y, Jiang Q, Long H, Chen H, Wei J, Li X, Wang H, Xie D, Zeng C, Lei G. Trends and benefits of early hip arthroplasty for femoral neck fracture in China: a national cohort study. Int J Surg. 2024 Mar 1;110(3):1347-1355. doi: 10.1097/JS9.0000000000000794.

    PubMed 38320106
  • Long H, Xie D, Chen H, Wei J, Li X, Wang H, Zeng C, Lei G. Rural-urban differences in characteristics, postoperative outcomes, and costs for patients undergoing knee arthroplasty: a national retrospective propensity score matched cohort study. Int J Surg. 2023 Sep 1;109(9):2696-2703. doi: 10.1097/JS9.0000000000000494.

    PubMed 37247007

Questions about this trial

What is this clinical trial studying?

An observational study of Knee Arthropathy and Hip Arthropathy, run by Xiangya Hospital of Central South University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Epidemiological characteristics, complications, risk factors and resource utilization of knee arthroplasty in China (time frame: 10 years (2013-2022)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05170321, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in